chr8-28503022-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017412.4(FZD3):c.9G>T(p.Met3Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,612,232 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00030 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
FZD3
NM_017412.4 missense
NM_017412.4 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: 0.324
Genes affected
FZD3 (HGNC:4041): (frizzled class receptor 3) This gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. The function of this protein is unknown, although it may play a role in mammalian hair follicle development. Alternative splicing results in multiple transcript variants. This gene is a susceptibility locus for schizophrenia. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009997547).
BS2
High AC in GnomAd4 at 45 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FZD3 | NM_017412.4 | c.9G>T | p.Met3Ile | missense_variant | 3/8 | ENST00000240093.8 | NP_059108.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FZD3 | ENST00000240093.8 | c.9G>T | p.Met3Ile | missense_variant | 3/8 | 1 | NM_017412.4 | ENSP00000240093 | P1 | |
FZD3 | ENST00000537916.2 | c.9G>T | p.Met3Ile | missense_variant | 2/7 | 2 | ENSP00000437489 | P1 | ||
FZD3 | ENST00000523546.1 | c.9G>T | p.Met3Ile | missense_variant | 2/2 | 2 | ENSP00000430125 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152202Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
45
AN:
152202
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000719 AC: 18AN: 250218Hom.: 0 AF XY: 0.0000740 AC XY: 10AN XY: 135226
GnomAD3 exomes
AF:
AC:
18
AN:
250218
Hom.:
AF XY:
AC XY:
10
AN XY:
135226
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1459912Hom.: 0 Cov.: 29 AF XY: 0.0000124 AC XY: 9AN XY: 726332
GnomAD4 exome
AF:
AC:
23
AN:
1459912
Hom.:
Cov.:
29
AF XY:
AC XY:
9
AN XY:
726332
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000295 AC: 45AN: 152320Hom.: 1 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74496
GnomAD4 genome
AF:
AC:
45
AN:
152320
Hom.:
Cov.:
33
AF XY:
AC XY:
19
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
10
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2023 | The c.9G>T (p.M3I) alteration is located in exon 3 (coding exon 1) of the FZD3 gene. This alteration results from a G to T substitution at nucleotide position 9, causing the methionine (M) at amino acid position 3 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;N
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;.;B
Vest4
MutPred
Gain of catalytic residue at M3 (P = 0.0227);Gain of catalytic residue at M3 (P = 0.0227);Gain of catalytic residue at M3 (P = 0.0227);
MVP
MPC
0.69
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at